Results 271 to 280 of about 615,884 (310)

A bibliometric analysis of research trends and global perspectives on lung large cell neuroendocrine cancer. [PDF]

J Thorac Dis
Wang X, Wu L, Pan C, Xu S.
europepmc   +1 more source

The relationship between the expression and clinicopathology of long non-coding RNA in older adults with non-small cell lung cancer. [PDF]

Medicine (Baltimore)
Liu H, Feng Z, Quan Q, Yang S, Chen Q.
europepmc   +1 more source

CD26 as a potential therapeutic target for lung adenocarcinoma. [PDF]

Front Oncol
Jungraithmayr W, Ohm B, Haberecker M, Curioni-Fontecedro A, Janker F, Gil-Bazo I, Soltermann A, Kirschner M, Weder W, Opitz I, Jang JH.   +10 more
europepmc   +1 more source

The continued importance of surgical resection in the management of pulmonary neuroendocrine tumours. [PDF]

J Thorac Dis
Starova U, Herrmann D, Oggiano M, Walles T, Hecker E.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Genes and Pathology of Non-Small Cell Lung Carcinoma

Seminars in Oncology, 2014
While histopathology has traditionally been the cornerstone of treatment decisions in the management of lung cancer patients, the complexity and heterogeneity of histological classification has had a limited impact in the routine practice of oncology. This has changed dramatically in the last few years, owing to discoveries of genomic aberrations and ...
Shingo, Sakashita, Mai, Sakashita, Ming, Sound Tsao   +2 more
openaire   +2 more sources

Integrin expression in non-small cell carcinoma of the lung

Cancer and Metastasis Reviews, 1995
Alteration of integrin expression in a number of different malignant diseases has been recognized, with a trend of downregulation of collagen-laminin binding integrin expression in epithelial tumor types noted. This study evaluated the expression of a panel of integrin subunits that included subunits that form receptors that bind to collagen and ...
W R, Smythe, E, LeBel, J E, Bavaria, L R, Kaiser, S M, Albelda   +4 more
openaire   +2 more sources

Non-Small-Cell Carcinoma of the Lung

1991
It is estimated that in the United States during 1989, 155000 cases of carcinoma of the lung will occur and that close to 142000 of these patients will die within 1 year from their disease (Silver-Berg and Lubera 1989). At present in the United States, the incidence and death rate from this disease for females has surpassed that for breast cancer in ...
Hassan Aziz, C. Julian Rosenthal, Louis Potters, Mohan Nuthakki, Marvin Rotman   +4 more
openaire   +1 more source

Curative radiotherapy in non-small cell carcinoma of the lung

International Journal of Radiation Oncology*Biology*Physics, 1990
Recent reports suggest radiotherapy administered to the 5000-6000 cGy level can result in significant long-term survival in non-small cell carcinoma of the lung. This is particularly true for many cases that are technically operable but for medical or other reasons thoracotomy cannot be performed.
B M, Talton, W C, Constable, C R, Kersh
openaire   +2 more sources

Molecular Diagnostics in Non-Small Cell Lung Carcinoma

Seminars in Respiratory and Critical Care Medicine, 2020
AbstractCurrent clinical practice guidelines recognize EGFR, BRAF, ALK, and ROS1 as essential molecular biomarkers, and a host of other genetic alterations as emerging biomarkers for non-small cell lung carcinoma patients. The available approaches to detecting relevant alterations in these genes are diverse and often complementary.
openaire   +2 more sources